Trial Profile
Prospective Multicenter Phase II Trial of 15-Minute Panitumumab Infusion with Irinotecan in Patients with Kras Wild-Type Chemo-Refractory Metastatic Colorectal Cancer: the Ship Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Oct 2015
Price :
$35
*
At a glance
- Drugs Irinotecan (Primary) ; Panitumumab (Primary)
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms SHIP
- 21 Oct 2015 New trial record
- 28 Jun 2014 Results presented at the 16th World Congress on Gastrointestinal Cancer.